Ponsegromab Crashes Out in Frailer Heart Failure Patients

by MrezaMk October 3, 2025

written by MrezaMk October 3, 2025 0 comments

(MedPage Today) — MINNEAPOLIS — Disappointingly, a growth differentiation factor 15 (GDF-15) neutralizer not only failed to improve functional outcomes in heart failure (HF) but was associated with harm in a trial that was terminated early…

You Might Also Like

Can a Dementia Drug Help Some Kids With Autism?
It’s Time to Get a Flu Vaccination. Here’s Who Needs One and Why.
Mitigating the Risk For Tardive Dyskinesia in Elderly Patients on Antipsychotics
Looming Health Insurance Spikes for Millions Are at the Heart of Federal Shutdown

Useful Links

Edtior's Picks

Latest Articles

Are you sure want to unlock this post?

Are you sure want to cancel subscription?

Queue